Cure My Disease

Don't miss your cure!

 Log in / Sign up

First human study of BMS-986368 begins in healthy chinese volunteers

NCT ID NCT07700329

Not yet recruiting Knowledge-focused Sponsor: Celgene Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This phase 1 trial tests an experimental drug called BMS-986368 in 16 healthy Chinese adults. The main goal is to measure how the drug moves through the body and to check for any side effects. Participants receive either the drug or a placebo, and researchers monitor safety through blood tests, vital signs, and heart tracings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an experimental drug called BMS-986368
What this could lead to
If successful, this study could provide early safety data to support further development of BMS-986368 for potential future treatments.
What could go wrong
This is a very early phase 1 trial with only 16 healthy participants, so results may not predict effects in patients. The drug may cause unexpected side effects or fail in later studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.